Voyager Therapeutics, Inc. Total Contract Liability
Voyager Therapeutics, Inc. (VYGR) had Total Contract Liability of $11.83 million as of 2022-12-31, per its 10-K filed 2023-03-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2023-03-07
- 2022-12-31: Contract with Customer, Liability $11.83M.
- 2022-09-30: Contract with Customer, Liability $10.02M.
- 2022-06-30: Contract with Customer, Liability $10.88M.
- 2022-03-31: Contract with Customer, Liability $11.44M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2022-12-31 | $11.83M 10-K · filed 2023-03-07 |
| 2022-09-30 | $10.02M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $10.88M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $11.44M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $12.10M 10-K · filed 2023-03-07 |
| 2021-09-30 | $39.18M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $39.73M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $40.06M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $43.69M 10-K · filed 2022-03-08 |
| 2020-09-30 | $45.67M 10-Q · filed 2020-11-09 |
| 2019-12-31 | $70.04M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |